Filtered By:
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 3003 results found since Jan 2013.
Diagnosis of a Rabbit Hemorrhagic Disease Virus 2 (RHDV2) and the Humoral Immune Protection Effect of VP60 Vaccine
This study suggested that the clinical application of VP60 may provide new ideas for preventing the spread of RHD2.PMID:37623236 | PMC:PMC10453004 | DOI:10.3390/cimb45080417
Source: Current Issues in Molecular Biology - August 25, 2023 Category: Molecular Biology Authors: Zhaoming Li Kaimin Song Yongzhen Du Zhuanglong Zhang Rupeng Fan Pimiao Zheng Jianzhu Liu Source Type: research
Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study
CONCLUSIONS: PCV13 vaccination among children aged 0-5 years substantially reduced the incidence of all-cause pneumonia. Direct immunization of children under 5 years is an effective strategy to combat outpatient pneumonia, and hospitalized pneumonia.PMID:37620204 | DOI:10.1016/j.vaccine.2023.08.041
Source: Vaccine - August 24, 2023 Category: Allergy & Immunology Authors: Jie Tian Bo Zheng Laibao Yang Ying Guan Chunze Xu Weibing Wang Source Type: research
Pneumococcal Vaccination in Adults
Am J Nurs. 2023 Sep 1;123(9):48-51. doi: 10.1097/01.NAJ.0000978148.47780.7f.ABSTRACTThe Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recently updated the adult pneumococcal vaccine recommendations to include two new pneumococcal conjugate vaccines (PCVs): PCV15 and PCV20. The authors review the updated guideline recommendations, their advantages and disadvantages, and nursing implications.PMID:37615467 | DOI:10.1097/01.NAJ.0000978148.47780.7f
Source: The American Journal of Nursing - August 24, 2023 Category: Nursing Authors: Joseph Walter Nicole Rudawsky Source Type: research
